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ABSTRACT
Objectives: This study aims to evaluate bone response to an implant surface modified by 1α,25-dihydroxyvitamin 
D3 [1.25-(OH)2D3] in vivo and the potential link between 1.25-(OH) 2D3 surface concentration and bone response.
Material and Methods: Twenty-eight implants were divided into 4 groups (1 uncoated control, 3 groups coated with 
1.25-(OH)2D3 in concentrations of 10-8, 10-7 and 10-6 M respectively), placed in the rabbit tibia for 6 weeks. Topographical 
analyses were carried out on coated and uncoated discs using interferometer and atomic-force-microscope (AFM). Twenty-
eight implants were histologically observed (bone-to-implant-contact [BIC] and new-bone-area [NBA]).
Results: The results showed that the 1.25-(OH)2D3 coated implants presented a tendency to osseointegrate better than the non-
coated surfaces, the differences were not significant (P > 0.05). 
Conclusions: The effect of 1.25-(OH)2D3 coating to implants suggested possible dose dependent effects, however no 
statistical differences could be found. It is thought that the base substrate topography (turned) could not sustain sufficient 
amount of 1.25-(OH)2D3 enough to present significant biologic responses. Thus, development a base substrate that can sustain 
1.25-(OH)2D3 for a long period is necessary in future studies.
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INTRODUCTION
Implant surface features plays a key role in the 
quality and rate of osseointegration [1]. Recent 
investigations have reported that along with the 
surface topographical modifications, the application 
of bioactive agents may result in enhanced osteogenic 
properties to the implant surface [2-4]. Bioactive 
implants have been reported to possibly develop a 
biochemical bonding between the bone tissue and the 
titanium implant surface rather than a merely physical 
one [5,6]. A bioactive implant surface is defined 
as one that has the potential to promote numerous 
molecular interactions, potentially forming a chemical 
bond between bone and implant surface [6]. Previous 
studies have demonstrated that proteins or peptides 
with bioactive capacity such as bone morphogenetic 
proteins (BMPs), fibronectin, type I collagen, 
fibroblast growth factor (FGF), and arginine-glycine-
aspartic acid (RDG-peptide) are promising bioactive 
molecular candidates with a high osteogenic potential 
[7-9]. However, their fabrication and economic 
feasibility along with technical and regulatory issues 
have led researchers to explore alternative bioactive 
molecules such as the bone mobilizing hormone - 
vitamin D.
Vitamin D has been shown to play an essential role 
in bone mineral homeostasis and in its active form, 
1α,25-dihydroxyvitamin D3 [1.25-(OH)2D3], may act 
as a bioactive protein promoting new bone formation 
[10,11]. The most important role of 1.25-(OH)2D3 
is that it regulates the intestinal adsorption of 
calcium and phosphate, resulting in increased plasma 
concentrations [12]. However, to date, the exact role 
of 1.25-(OH)2D3 in osteogenesis has yet to be fully 
explored since the hormone effects multiple cellular 
pathways [13,14]. 
Previous studies have reported that 1.25-(OH)2D3 
significantly promoted the expression of osteogenic 
markers, in addition, 1.25-(OH)2D3 deficiency 
negatively impacts osseointegration [15,16]. It has 
been suggested that 1.25-(OH)2D3 has a direct effect 
on osteogenesis since vitamin D receptors (VDR) are 
present on osteoblasts and osteoclast precursors, with 
activation leading to RANKL expression [17,18]. 
Masuyama et al. [16] reported in their in vivo study 
using mice that 1.25-(OH)2D3 exerted a regulatory 
effect on osteoblast and osteoclast chemotaxis during 
increasing vascular tissue infiltration. Furthermore, 
Masuyama et al. [16] showed that 1.25-(OH)2D3 
could regulate collagen modification and maturation 
in an osteoblastic cell culture, which has been 
proven to be important in early bone formation [19]. 
Numerous studies have also suggested that these 
intriguing osteogenic influences of 1.25-(OH)2D3 are 
dose dependent [17,20,21].
Even though previous in vitro studies of 1.25-(OH)2D3 
suggest its promising effects on osteogenesis, the in 
vivo biologic responses have not yet been confirmed 
especially when attached to implantable materials. 
The aim of this study was to histologically evaluate 
the osteogenic effect of 1.25-(OH)2D3 coatings to 
endosteal implant surfaces  and to determine if the 
biologic response would be doses dependent of 
1.25-(OH)2D3 concentration on the surface.
MATERIAL AND METHODS
Surface preparations
Twenty-eight commercially pure machine turned 
titanium implants (Grade 4, Neodent® Curitiba, 
Brazil), 7 mm in length and 3.75 mm in diameter 
were used in this study. The implants were divided 
into 4 groups with 7 implants in each group, with 
one functioning as an uncoated control group. The 
remaining groups were coated with 1.25-(OH)2D3 in 
concentrations of 10-8, 10-7 and 10-6 M respectively, 
based on a previous in vitro investigation [18]. 
1.25-(OH)2D3 was diluted in ≥ 99.5% ethanol until 
desired concentrations were achieved. The implants 
were soaked in the respective solution for 1 h and 
thereafter were gently rinsed with phosphate buffered 
saline (Invitrogen, GIBCO, Sweden) and finally were 
air-dried in a 24-well plate. The well was covered 
with lab-foil and stored in a freezer prior to surgery. 
For topographical investigation, 3 discs (8 mm in 
diameter, 1 mm in thickness) of turned commercially 
pure titanium (grade 4) were soaked in each solution 
(a total of 9 discs) following the same procedure as 
when soaking the implants.
Topographic analysis
An optical interferometer (MicroXam; ADE 
Phase Shift Technology, Inc., Tucson, AZ) was 
used to characterize the topography of 3 uncoated 
implants. All twelve discs were also measured with 
interferometer at 3 randomly selected sites and 
thereafter topographically compared to each other. 
The following topographical parameters were used: 
Sa (µm) = average height deviation from a mean 
plane, Sds (µm-2) = density of summits and Sdr (%) = 
developed surface ratio [22]. Before the parametrical 
calculation could be evaluated, the waviness from the 
surface was removed using a 50 × 50 µm Gaussian 
filter. For each selected scan area, the mean value 
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and standard deviation of the parameters were 
obtained from 9 scans of each group (a total of thirty-
six measurements), from random sites on the surface.
In order to obtain the surface roughness in the 
nanometer length scale, atomic-force-microscopy 
(AFM, XE-100, Park Systems Corp, Suwon, 
Korea) was utilized on the same twelve discs. For 
the measurements, 3 different scanning areas were 
selected (10 × 10 µm, 5 × 5 µm and 1 × 1 µm). The 
images obtained by AFM were subjected to levelling 
and applied Gaussian filtering with a cut-off of 2.5 µm 
(for 10 × 10 µm scans), 1 µm (for 5 × 5 µm scans), 
and 0.25 µm (for 1 × 1 µm scans), using the software 
MontainsMap 6 (Digital Surf, Besançon, France) and 
the same three-dimensional parameters used for the 
interferometer (Sa, Sdr, Sds) were evaluated to correlate 
to the micro roughness. For each selected scan 
area, the mean value and standard deviation of the 
parameters were obtained from 9 scans of each group 
(a total of thirty-six measurements), from random 
sites on the surface.
Animal preparation
Twelve New Zealand white rabbits (mean body weight 
4.7 kg [range 3.8 - 5.2 kg]) were used in this study. 
The study was approved by the Ethics Committee for 
Animal Research at the École Nationale Vétérinaire 
d’Alfort (Maisons-Alfort, Val-de-Marne, France). All 
surgical procedures were performed under general 
anaesthesia. The pre-anaesthetic procedure comprised 
an intra-muscular administration of atropine sulfate 
(0.044 mg/kg) and xylazine chlorate (8 mg/kg). 
General anaesthesia was then obtained following an 
intra-muscular injection of ketamine chlorate (15 
mg/kg). Thereafter, the hind legs were shaved and 
disinfected with iodine solution. After anaesthetic and 
disinfection procedures, the proximal tibiae on both 
sides were exposed and 4 osteotomy sites (2 in each 
leg) were prepared according to the manufacturer’s 
instructions for placement of implants in dense bone, 
i.e., to avoid excessive torque.
Histological preparation and analyses
Table 1. Mean values for Sa, Sdr, Sds (standard deviation) for topographical analyses 














0 0.3 (0.02) 6 (0.1) 129339 (1374) 3
10-8 0.3 (0.03) 8.1 (1.8) 143980.5 (4187. 4) 3
10-7 0.3 (0.06) 5.5 (1.3) 131965.2 (4142.4) 3
10-6 0.3 (0.07) 5.9 (1.3) 131705.8 (9496.7) 3
P-value 0.503 0.074 0.049
After 6 weeks of healing, the animals 
were euthanized with anaesthesia 
overdose and the implants were removed 
en bloc and thereafter were placed 
in 4 % formaldehyde for 24 h. After 
fixation, the samples were subjected 
to dehydration in a series of ethanol 
(70 - 100%) and infiltration in resin 
(30 - 100%) under constant vacuuming 
and thereafter were embedded in light curing-resin 
(Technovit 7200 VLC; Heraeus Kulzer, Wehrheim, 
Germany). The embedded resin blocks were subjected 
to non-decalcified cut and grind sectioning. In brief, 
a central section of each sample were prepared using 
the EXAKTTM cutting and grinding equipment to a 
final thickness of 15 µm. After polishing to exclude 
scratches, the sections were finally stained with a 
mixed solution of toluidine blue and pyronin G. 
The histological analyses were performed using a 
light microscope (Eclipse ME600; Nikon, Japan) 
and the histomorphological data was analyzed with 
image analysis software (Image J v. 1.43u; National 
Institute of Health). Calculation of bone-to-implant 
contact (BIC) ratio along the implants surfaces and 
new-bone-area (NBA) within the threads were made 
using a x10 magnification objective. Histology and 
histomorphometry were both conducted in a blind 
manner.
Statistical analysis
The statistical analyses of the mean values of the 
discs topography were composed and compared 
using One-Way Analysis of Variance (ANOVA). 
The statistical significance level was set at P ≤ 0.05. 
Histological multiple group comparisons were 
performed by computer software SPSS for Macintosh 
(SPSS Inc., Chicago, IL, USA). The results from the 
histomorphometric measurements were expressed 
as means and standard deviations (M [SD]). 
The different treatment groups were compared using 
Kruskal Wallis with the significance level set at 
P ≤ 0.05. 
RESULTS
Topographical analyses
Topographical analyses of the discs with the 
interferometer showed a statistical significant 
difference (P = 0.049) regarding the density of 
summits in µm-2 (Sds), as presented in Table 1. 
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The 1.25-(OH)2D3 coating did not yield any significant 
differences in surface topography parameters in the 
micro level for the average height derivation in µm 
(Sa) or for the developed surface ratio in % (Sdr) (both 
dependent variables at P > 0.05).
Topographical analyses in the nanometer level with 
AFM showed no significant differences (P > 0.05) 
between all groups tested (Table 2 - 4).
The descriptive images for both interferometer and 
AFM are presented in Figure 1. The investigation 
of samples by interferometer showed no qualitative 
differences in the morphology of the surface between 
the control and test groups. The image scans obtained 
from AFM also showed no qualitatively distinct 
differences in the surface morphology between all groups 
(only some examples of scans 1 x 1 µm are shown).
Table 2. Mean values for Sa for µm (standard deviation) for topographical analyses of discs with AFM in 3 different magnifications and 







10 x 10 μm 5 x 5 μm 1 x 1 μm Quantity
0 0.05 (0.006) 0.02 (0.005) 0.005 (0.0005) 9
10-8 0.05 (0.006) 0.02 (0.0007) 0.007 (0.001) 9
10-7 0.05 (0.003) 0.02 (0.03) 0.007 (0.002) 9
10-6 0.05 (0.005) 0.02 (0.005) 0.009 (0.003) 9
P-value 0.932 0.938 0.126
Table 3. Mean values for Sdr in % (standard deviation) for topographical analyses of discs with AFM in three different magnifications and 







10 x 10 μm 5 x 5 μm 1 x 1 μm Quantity
0 11.7 (1.8) 10.3 (4.6) 36.3 (48.1) 9
10-8 11.4 (2.9) 10.8 (1.6) 46.9 (32.1) 9
10-7 13.4 (0.7) 12.3 (2.9) 48 (48) 9
10-6 13.3 (3.3) 13.9 (5) 39.5 (24) 9
P-value 0.65 0.66 0.978
Table 4. Mean values for Sds in µm-2 (standard deviation) for topographical analyses of discs with AFM in three different magnifications and 







10 x 10 μm 5 x 5 μm 1 x 1 μm Quantity
0 12.9 (6.4) 33.9 (15.6) 2434.6 (2111.6) 9
10-8 15.9 (4.1) 49.6 (18.9) 2472.6 (1327) 9
10-7 18.6 (7.8) 53.2 (27.1) 2725.9 (888.1) 9
10-6 13.6 (1.6) 39.3 (4.3) 2262.2 (1677.8) 9
P-value 0.602 0.575 0.978
Figure 1. Descriptive IFM and AFM three-dimensionally reconstructed images of the groups tested in the study.
IMF
AMF
10-8 M 10-7 M 10-6 MControl
http://www.ejomr.org/JOMR/archives/2014/3/e3/v5n3e3ht.htm J Oral Maxillofac Res 2014 (Jul-Sep) | vol. 5 | No 3 | e3 | p.5
(page number not for citation purposes)
JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH                                                                    Naito et al. 
Histological evaluation
The animals recovered without complications and 
no signs of infection were noted upon clinical 
examination at any time during the observation period.
The mean BIC in percentage was 4.4 (1.9) for the 
control group (0 M), 8.7 (4.6) for group I (10-8 M), 
8.2 (3.3) for group II (10-7 M) and 7.4 (3.8) for group 
III (10-6 M), respectively. The experimental group 
Table 5. Mean values in percentage (standard deviation) for 







BIC total NBA total Quantity
0 4.4 (1.9) 16.7 (8) 7
10-8 8.7 (4.6) 16.5 (4.2) 7
10-7 8.2 (3.3) 15.4 (8.1) 7
10-6 7.4 (3.8) 16.1 (11.1) 7
P-value 0.162 0.775
BIC = bone-to-implant-contact; NBA = new bone area.
Table 6. Mean values in percentage (standard deviation) on 
the comparison between control vs coated groups (the effect of dose 
was collapsed) and P-values for one-way ANOVA
BIC total NBA total Quantity
Control 4.4 (1.9) 16.7 (8) 7
VD-coating 8.1 (3.8) 16 (7.9) 21
P-value 0.27 0.756
BIC = bone-to-implant-contact NBA = new bone area.
Figure 2. Mean values in percentage (%) of bone-to-implant- 
contact (BIC) around the total dental implant for each tested group.
Figure 3. Mean values in percentage (%) of new bone area (NBA) 
around the total dental implant for each tested group.
Figure 4. Mean values (non-coating vs. coating) in percentage (%) 
of bone-to-implant-contact (BIC) around the total dental implant. 
aStatistical significance (P < 0.05).
showed a trend toward higher bone contact, however 
the results were not statistically significant (Figure 2, 
Table 5). The means for NBA in percentage were 
16.7 (8) for the control group, 16.5 (4.2) for group I, 
15.4 (8.1) for group II and 16.1 (11.1) for group III, 
respectively, with no significant differences between 
each of the groups (Figure 3, Table 5). When the 
effect of dosage was collapsed and statistically 
compared to the control, there was a statistically 
significant effect of the vitamin D coating in BIC 
(P < 0.05) (Figure 4, Table 6). However, no significant 
differences were found in NBA (P > 0.05) (Figure 5, 
Table 6).
Figure 5. Mean values (non-coating vs. coating) in percentage (%) 
of new bone area (NBA) around the total dental implant.
Concentration of 1.25-(OH) 2D3 (M)
Concentration of 1.25-(OH) 2D3 (M)
Concentration of 1.25-(OH) 2D3 (M)
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Figure 6 illustrates descriptive optical microscope 
images of the histological section from the uncoated 
control group and the coated groups. For all groups, 
newly formed bone was intact to the implant 
and no signs of inflammation or the presence of 
multinucleated giant cells were seen. 
DISCUSSION
This study aimed to histologically evaluate the 
biologic effect of 1.25-(OH)2D3 coated onto implant 
surfaces. It was hypothesized that the biologic 
response would be distinct depending on the dosage of 
1.25-(OH)2D3 applied to the implant surface.
It has been suggested that the optimal Sa value to 
obtain good bone response is between 1 - 1.5 µm, 
which is the so-called moderately roughened implant 
surface [23]. While surface roughness has been 
shown to affect bone response we utilized a smooth 
turned metal surface to examine the effect of the 
1.25-(OH)2D3 coating without underlying implant 
roughness. This methodology has been used in other 
studies experimentally attempting to determine 
the effect of various protein or calcium phosphate 
coatings on the bone-to-implant response [8,24,25]. 
While the surface roughness values between all 
groups tested were similar, there were significant 
differences in the density of summits (Sds) between 
groups (P = 0.049). This significance is probably due 
to the different 1.25-(OH)2D3 coating concentrations, 
as the test groups showed higher mean values than 
control group (Table 1), thus the coatings may 
have resulted in changes to the surface topography. 
Interestingly, the AFM measurements demonstrated 
no statistical differences between all groups tested in 
the nanometer length scale (Table 2 - 4), despite each 
group presenting different qualitative topographical 
features as seen in the three-dimensional reconstructed 
images. Overall, the interferometer and AFM results 
indicate that coatings of 1.25-(OH)2D3 slightly altered 
the surface topography in a dose dependent manner, 
which may have influenced the host biological 
responses. 
Previous studies have shown that vitamin D is 
dose dependent in serum [17,21] but it should also 
be noted that vitamin D also has a bone resorbing 
effect, especially with high therapeutic doses [17]. 
Thus, the selection of the optimal concentration 
must be determined based on further evidence. 
Figure 6. Histological photographs of the bone tissue formed around all tested groups after 6 weeks of implantation. Original magnification 
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Moreover, it remains to be identified how much 
coating agent remains on the implant because the 
specimens were coated with the traditionally utilized 
dip coating, furthermore, turned surface implants 
were the base substrates. It is thought that one reason 
for the small differences between all groups in terms 
of histomorphometry was that the dip coating on the 
turned surface did not assure stable protein adsorption 
to the surface and the 1.25-(OH)2D3 simply remained 
after air drying. Thus, naturally, the release of the 
protein was a rapid process, which could not provide 
a sufficient bone forming effect. In future studies, the 
amount of protein adsorption to a modified textured 
surface, and its release rate should be determined 
in order to obtain the optimal surface for protein 
incorporation. 
This study intended to investigate a possibly bioactive 
implant surface with the use of different 1.25-(OH)2D3 
concentrations. Although there was a tendency for 
the 1.25-(OH)2D3 coated implants to show better bone 
responses, the results were not significant. Thus, an 
implant surface that can sustain the 1.25-(OH)2D3 over 
a long period of time should be considered.
CONCLUSIONS
The current study demonstrated that there may be 
dose dependent biologic effects of the 1.25-(OH)2D3 
in vivo, however the differences were insignificant 
within the limitation of the study.
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